$TLTFF Value Driven Milestones & Upcoming Catalysts

Q1’ 12 – Successful preclinical studies showing complete destruction of various brain and colon cancer cell lines in-vivo and in live animal trials using Theralase PDCs

Q3’ 12 – Bladder Cancer identified as primary target for Advanced Photo Dynamic Therapy in FDA clinical trials

Q3’ 12 – Developed commercialization path for PDC technology to FDA Phase 1/2a clinical trials

Q4’ 13 – TLC-2000 Therapeutic biofeedback medical laser to be launched to healthcare practitioners

Q1’ 14 – Entering FDA phase 1 bladder cancer clinical trials

Q4’ 15 – Successfully completed 12 month follow-up of bladder cancer clinical trial.